Navigation Links
The John Theurer Cancer Center to host Seventh Annual Neuro-Oncology Symposium
Date:5/9/2011

HACKENSACK, N.J. (May 9, 2011) The John Theurer Cancer Center at Hackensack University Medical Center will host the Seventh Annual Neuro-Oncology Symposium on Friday, May 20 from 7:30am - 1:00pm. This continuing medical education (CME) conference will present the latest neuro-oncology trends by leaders in the field.

"For the seventh consecutive year, we are able to bring together leaders in neuro-oncology to provide insights on the latest advancements in the neuro-oncology field," said Viswanathan Rajaraman, M.D., Co-Chief of Neuro-Oncology at the John Theurer Cancer Center. "We are proud to bring together a group of highly esteemed oncologists to our new comprehensive cancer center to discuss the latest trends in our field."

Topics to be discussed at the Seventh Annual Neuro-Oncology Symposium: Controversies in Neuro-Oncology and Para Neoplastic Syndromes Affecting the CNS include controversies in radiosurgery and whole brain radiotherapy in metastatic brain tumors, management of para neoplastic syndrome, management of low grade gliomas, and identifying pitfalls in neuro-oncology imaging.

"The John Theurer Cancer Center is committed to helping our staff and the tri-state area neuro-oncology medical community stay up-to -date with the latest medical advancements through educational programs," said Mark Pascal, M.D., Co- Chief, Neuro-Oncology, John Theurer Cancer Center.

The program will feature neuro-oncology experts from world-renowned institutions such as Memorial Sloan-Kettering Cancer Center, Roswell Park Cancer Institute and University of Virginia Health System. Featured speakers include:

  • Jerome Posner, M.D., Memorial Sloan-Kettering Cancer Center, New York, NY
  • Dheerendra Prasad, M.D., Roswell Park Cancer Institute, Buffalo, NY
  • David Schiff, M.D., University of Virginia Health System, Charlottesville, VA
  • Andrei Holodny, M.D., Memorial Sloan-Kettering Cancer Center, New York, NY

"It is part of our mission at the John Theurer Cancer Center to promote research and innovation through education," said Andrew L. Pecora, M.D., C.P.E., F.A.C.P., Chief Innovations Officer and Professor and Vice President of Cancer Services at the John Theurer Cancer Center. "The Neuro-Oncology Symposium is just one example of the superior continuing medical education programs we offer throughout the year."

This program is open to the public, but is designed for neurologists, neurosurgeons, medical oncologists, radiation oncologists, internists, primary care physicians, neuropsychologists, other physicians and healthcare providers. Hackensack University Medical Center designates this educational activity for a maximum of 4.0 AMA PRA Category 1 Credit(s). The program will be held at the John Theurer Cancer Center at Hackensack University Medical Center, 92 Second Street, Hackensack, NJ in the #2 conference room.

This event is complimentary, however registration is required. To register, please contact Maryann V. Lederhilger at (551) 996-1162 or mlederhilger@humed.com. For updates and additional information, please visit jtcancercenter.org/neurooncologyCME.


'/>"/>

Contact: Jaymie DeGaetano
jaymie.degaetano@widmeyer.com
646-213-7243
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. John Theurer Cancer Center first in New Jersey to offer complete capabilities of Provenge
2. The MMRF and John Theurer Cancer Center to host patient symposium
3. John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques
4. John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference
5. Oncology basic research director at John Theurer Cancer Center continues transplantation research
6. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
7. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
8. John Theurer Cancer Center to present innovative research at 2 surgical meetings
9. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
10. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
11. The John Theurer Cancer Center recognizes medical physics team for safety track record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... ... a 2017 Best in KLAS category winner, has named Daniel P. Bullington as ... and enhance its technology platform and product offerings,” says Justin Neece, president. “Daniel ...
(Date:5/23/2017)... ... May 23, 2017 , ... The Gallery of Cosmetic Surgery, ... pleased to announce a new treatment option called Vivace Microneedling. This treatment option ... and body through a virtually pain-free, non-surgical treatment. Vivace Microneedling combines a state-of-the-art, ...
(Date:5/23/2017)... ... May 23, 2017 , ... MedTech For Solutions has announced ... laboratory, to provide hands-on training utilizing cutting-edge equipment at its recently-opened OvaTools Andrology ... MedTech Group Purchasing vendor , will provide specialized equipment to ensure OvaTools participants ...
(Date:5/23/2017)... , ... May 23, 2017 , ... Orbita’s Nathan Treloar ... May 23, 2017 in San Francisco. Titled Connected Health and IoT: Technology Innovators ... Event hosted by Parks Associates, a market research and consulting firm specializing in ...
(Date:5/23/2017)... ... 2017 , ... Therachat , a smart guided journaling tool for improving ... current state of anxiety in support of National Mental Health Awareness Month. , The ... and benchmarked general anxiety levels as well as identified the top triggers, impact to ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health ... announced that it is teaming up with Auto Control ... lower diabetes healthcare costs in Canada ... available throughout all provinces and territories in ... additional savings when shopping for Dario supplies in local ...
(Date:5/3/2017)... Md. , May 3, 2017  Kalorama ... growth of nine percent next year and this ... organ and hematopoietic stem cell (HSCT) or bone ... donor. Molecular testing technologies are well-suited for this task. ... market research publisher Kalorama Information. The various PCR-based ...
(Date:5/2/2017)... SYDNEY , May 2, 2017  George Clinical, ... Asia-Pacific region, and Vector Oncology, a ... research and data analytics, formally announced today that George ... immediately, the transaction has the dual purpose of ... scientifically led oncology trial delivery solutions throughout the ...
Breaking Medicine Technology: